http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#Head
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#assertion
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#provenance
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#pubinfo
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#assertion
http://purl.obolibrary.org/obo/DOID_8469
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_8469
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00198
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
http://www.w3.org/2000/01/rdf-schema#label
tamiflu is an influenza neuraminidase inhibitor indicated for treatment of influenza in patients 1 year and older who have been symptomatic for no more than 2 days 1 1 prophylaxis of influenza in patients 1 year and older 1 2 important limitations of use efficacy not established in patients who begin therapy after 48 hours of symptoms 1 3 not a substitute for annual influenza vaccination 1 3 no evidence of efficacy for illness from agents other than influenza viruses types a and b 1 3 consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use 1 3 tamiflu is indicated for the treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older who have been symptomatic for no more than 2 days tamiflu is indicated for the prophylaxis of influenza in patients 1 year and older the following points should be considered before initiating treatment or prophylaxis with tamiflu efficacy of tamiflu in patients who begin treatment after 48 hours of symptoms has not been established tamiflu is not a substitute for early influenza vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices there is no evidence for efficacy of tamiflu in any illness caused by agents other than influenza viruses types a and b influenza viruses change over time emergence of resistance mutations could decrease drug effectiveness other factors for example changes in viral virulence might also diminish clinical benefit of antiviral drugs prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use tamiflu
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00198
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#provenance
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#pubinfo
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#sig
http://purl.org/nanopub/x/hasSignature
VIHf9tXz8WA9BTy0XLhbMfU2CG/HwVbvrvJ5+65H11ewrqgMQ+r35/Ya7Ms80sZN2W6BeU0QrcojmKVV0DKTTHQLT6BszMDn0h+XidySoD7IR4Yvt1apj9L3ibH7y8tlstVpagWuz9aMJIY69vOwiUu6iihe8qWF43alBszBeQY=
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://purl.org/dc/terms/created
2021-06-12T16:44:56.782+02:00
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAyIryxwdjDh1nppIOXe9YKv3OI9tkARZO-4_gLxK5aPM
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs